Chinese Journal of Cancer Research

Papers
(The TQCC of Chinese Journal of Cancer Research is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Pathogenic germline variants in mismatch repair genes in patients with microsatellite instability-high gastric cancer114
Molecular features of gastroenteropancreatic neuroendocrine carcinoma: A comparative analysis with lung neuroendocrine carcinoma and digestive adenocarcinomas79
Efficacy and safety of low-dose cyclophosphamide combined with lenvatinib, pembrolizumab and TACE for unresectable hepatocellular carcinoma: A single-center, prospective, single-arm clinical trial71
Transforming cancer cells for long-term living with cancer: An inspiring new approach53
Gastric cancer surgery in South Korea: Past, present, and future49
Efficacy of ctDNA methylation combined with traditional detection modality to detect liver cancer among high-risk patients: A multicenter diagnostic trial41
Focal ablation therapy presents promising results for selectively localized prostate cancer patients37
Clinical and molecular significance of homologous recombination deficiency positive non-small cell lung cancer in Chinese population: An integrated genomic and transcriptional analysis36
Advancements in diagnosis and treatments of acute leukemia35
Gut microbiota and acute graft-versus-host disease30
Plasma cell-free DNA methylation markers for detection and prognosis of gastric cancer: A case-control study27
Detection and classification of breast lesions using multiple information on contrast-enhanced mammography by a multiprocess deep-learning system: A multicenter study23
Current trends and future directions of artificial intelligence in lung cancer diagnosis21
Updates of CSCO guidelines for colorectal cancer version 202521
Tislelizumab in previously treated, locally advanced unresectable/metastatic microsatellite instability-high/mismatch repair-deficient solid tumors20
Microbiota and urinary tumor immunity: Mechanisms, therapeutic implications, and future perspectives19
Sequential neoadjuvant chemotherapy using pegylated liposomal doxorubicin and cyclophosphamide followed by taxanes with complete trastuzumab and pertuzumab treatment for HER2-positive breast cancer: A18
Development and validation of a multiparametric magnetic resonance imaging-based nomogram for predicting feasibility of sphincter-preserving surgery in mid-low rectal cancer18
Mn-based cGAS-STING activation for tumor therapy18
Multi-omics profile of exceptional long-term survivors of AJCC stage III triple-negative breast cancer18
Impact of resection margin status on survival in gastric cancer: A retrospective cohort study17
Is sentinel node navigation surgery feasible after non-curative endoscopic resection in patients with early gastric cancer?17
New roles of tumor-derived exosomes in tumor microenvironment17
Prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery: Final results of a phase II trial16
Optimal response population after neoadjuvant therapy for patients with locally advanced gastric cancer: A multicenter study16
Comparison of short- and long-term outcomes of robotic vs. laparoscopic gastrectomy for clinical serosa-invasive gastric cancer: A multicenter cohort study16
A multicenter study of a predictive model for pathological complete response after neoadjuvant therapy in breast cancer using multimodal digital biomarkers15
Clinicopathological significance and immunotherapeutic outcome of claudin 18.2 expression in advanced gastric cancer: A retrospective study14
Genomic characterization of peritoneal lavage cytology-positive gastric cancer14
Health economic evaluation on population-based Helicobacter pylori eradication and endoscopic screening for gastric cancer prevention14
Estimation of economic burden throughout course of cervical squamous intraepithelial lesion and cervical cancer in China: A nationwide multicenter cross-sectional study14
Breakthroughs in malignancy therapy: New advances and emerging trends in renal cell carcinoma14
Hypoxic tumor microenvironment: Destroyer of natural killer cell function14
Postoperative chemoradiotherapy with capecitabine and oxaliplatin vs. capecitabine for pathological stage N2 rectal cancer14
Long-term adherence to gastric cancer screening in South Korea: A 10-year follow-up study13
Immune status and combined immunotherapy progression in Kirsten rat sarcoma viral oncogene homolog (KRAS) mutant tumors13
Effect of microbiome group on immune checkpoint inhibitors in treatment of gastrointestinal tumors13
Research progress of minimally invasive surgery for gastric cancer13
Lung cancer burden and trends from 2000 to 2018 in China: Comparison between China and the United State12
Development and validation of machine learning-based survival analysis to predict outcome in gastric cancer with adjuvant chemotherapy: A multicenter, longitudinal, cohort study12
Adjuvant therapy for hormone receptor-positive breast cancer: Perspective from a survey on breast cancer physicians’ acceptance of practice-changing data12
Variant rs8400 enhances ALKBH5 expression through disrupting miR-186 binding and promotes neuroblastoma progression11
Predictive value of co-expression patterns of immune checkpoint molecules for clinical outcomes of hematological malignancies11
Advances, breakthroughs, and challenges in gastric cancer surgery11
SOX11 as a potential prognostic biomarker in hepatocellular carcinoma linked to immune infiltration and ferroptosis11
Preface to Special Issue: Breakthroughs in malignancy therapy: New advances and emerging trends—Awakening immune system: The new era of radioimmunotherapy10
High-risk extranodal natural killer/T-cell lymphoma patients could benefit more from allogeneic hematopoietic stem cell transplantation as consolidation: A real-world multicenter analysis in China10
Discovery and validation of indole nitroolefins as novel covalent GPX4 inhibitors for inducing ferroptosis in urological cancers10
Clinicopathological and molecular features of HR+/HER2− breast cancer patients with distinct endocrine resistance patterns10
Update of latest data for combined therapy for esophageal cancer using radiotherapy and immunotherapy: A focus on efficacy, safety, and biomarkers10
Integrating AI-driven single-cell analysis to decode epithelial heterogeneity: A prognostic signature and translational immunotherapy strategy targeting KRT18-induced PD-L1 in lung adenocarcinoma9
Molecular insights into immune evasion and therapeutic paradigms in pancreatic cancer9
Epidemiology, early detection, and management of breast cancer in China: A comprehensive review9
Allogeneic hematopoietic cell transplantation in vulnerable populations: Advances and perspectives8
Efficacy and safety of dacomitinib as first-line treatment for advanced non-small cell lung cancer patients with epidermal growth factor receptor 21L858R mutation: A multicenter, case-series study in 8
Homoharringtonine combined with venetoclax and azacitidine: An effective and safe regimen for patients with refractory/relapsed acute myeloid leukemia8
Myeloid cells meet CD8+ T cell exhaustion in cancer: What, why and how8
Chromatin regulators TOP2A and PPARGC1A stratify prostate cancer risk and reveal TOP2A-driven progression via PI3K/AKT pathway8
Distal margin distance in radical resection of locally advanced rectal cancer after neoadjuvant therapy8
Effectiveness and safety of combined nimotuzumab and S-1 chemotherapy with concurrent radiotherapy for locally advanced esophageal cancer in malnourished and elderly patients: A prospective phase II s8
0.049805879592896